DOW AGROSCIENCES LLC;FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
发明人:
EILEEN KNORR,ANDREAS VILCINSKAS,ELANE FISHILEVICH,WENY LO,PREMCHAND GANDRA,MURUGESAN RANGASAMY,MEGHAN L. FREY,SARAH E. WORDEN,KENNETH NARVA
申请号：
ARP160101563
公开号：
AR104814A1
申请日:
2016.05.27
申请国别(地区):
AR
年份:
2017
代理人:
摘要：
1. Claim 1: a nucleic acid molecule, including at least one polynucleotide molecule operatively connected with a heterogeneous developer, wherein the polynucleotide is selected from the following groups: sec ID No.1； sec supply No.1； sec ID No.1； at least 15 contiguous nucleic acid fragments； sec ID No.1； 1. Supplement at least 15 consecutive nucleotide fragments of SEC ID 1； the local coding sequence of a diabetic organism, including any one between sec 3-5； supplement the local coding sequence of a diabetic organism, including any one between sec 3-5；There are at least 15 contiguous nucleotide fragments in the local coding sequence of a diabetic organism, including any fragment between sections 3-5； and there are at least 15 contiguous nucleotide fragments in the local coding sequence of a diabetic organism, including any fragment between us. No.3-5. 150. Claim 5: a nucleic acid molecule (RNA) is transcribed from the nucleic acid molecule according to claim 1. Claim 15: claim unit 14,Where the cell is a plant cell. Claim 16: a factory that processes nucleic acid molecules in accordance with claim 1. Claim 25: a method for controlling insect pest population, which includes providing a physical agent containing a ribonucleic acid molecule to contact insect pests and inhibit biological functions in insect pests, a. RNA is a special inorganic group, which is selected from any combination of ID 71-74；D. Any complementarity between sections 81-84； at least 15 consecutive nucleotide fragments between any characteristic between sections D； at least 15 consecutive nucleotide fragments between sections D； any fragment between sections 81-84 of Section D； a transcript of any fragment between sections 1 and 3-5 of Section D； and a transcript See any document between d.d.1 and d.3-5； a copy of d.d.1 containing at least a portion of 15 consecutive nucleic acids； and a copy of d.d.1 containing at least a portion of 15 consecutive nucleic acids. Requirement 38: method of producin
